Larvol Delta - Alzamend-Neuro-Partners-with-Massachusetts-General-Hospital-for-a-Phase-II-Clinical-Trial-of-AL001-a-NextGeneration-Lithium-Therapeutic-Drug-Candidate-involving-Patients-with-Alzheimers-Disease

LISPRO (lithium/proline/salicylate) - Alzamend Neuro

https://www.businesswire.com/news/home/20240805950961/en/Alzamend-Neuro-Partners-with-Massachusetts-General-Hospital-for-a-Phase-II-Clinical-Trial-of-AL001-a-Next-Generation-Lithium-Therapeutic-Drug-Candidate-involving-Patients-with-Alzheimer%E2%80%99s-Disease

Aug 5, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next